Detalhe da pesquisa
1.
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles.
Cell
; 171(6): 1437-1452.e17, 2017 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29195078
2.
Reduced-representation Phosphosignatures Measured by Quantitative Targeted MS Capture Cellular States and Enable Large-scale Comparison of Drug-induced Phenotypes.
Mol Cell Proteomics
; 15(5): 1622-41, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26912667
3.
Proteomic profiling dataset of chemical perturbations in multiple biological backgrounds.
Sci Data
; 8(1): 226, 2021 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34433823
4.
Cas9 activates the p53 pathway and selects for p53-inactivating mutations.
Nat Genet
; 52(7): 662-668, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32424350
5.
Author Correction: Cas9 activates the p53 pathway and selects for p53-inactivating mutations.
Nat Genet
; 52(7): 748-749, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32587373
6.
A Library of Phosphoproteomic and Chromatin Signatures for Characterizing Cellular Responses to Drug Perturbations.
Cell Syst
; 6(4): 424-443.e7, 2018 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29655704
7.
A phosphoproteomic signature in endothelial cells predicts vascular toxicity of tyrosine kinase inhibitors used in CML.
Blood Adv
; 2(14): 1680-1684, 2018 07 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30021779